Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transthoracic ultrasound sign in severe asthmatic patients: a lack of "gliding sign" mimic pneumothorax.
Del Colle A, Carpagnano GE, Feragalli B, Foschino Barbaro MP, Lacedonia D, Scioscia G, Quarato CMI, Buonamico E, Tinti MG, Rea G, Cipriani C, Frongillo E, De Cosmo S, Guglielmi G, Sperandeo M. Del Colle A, et al. Among authors: carpagnano ge. BJR Case Rep. 2019 Nov 15;5(4):20190030. doi: 10.1259/bjrcr.20190030. eCollection 2019 Dec. BJR Case Rep. 2019. PMID: 31938562 Free PMC article.
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life.
Sposato B, Camiciottoli G, Bacci E, Scalese M, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Masieri S, Corsico A, Scichilone N, Baglioni S, Murgia N, Folletti I, Bardi G, Grosso A, Cameli P, Latorre M, Musarra A, Bargagli E, Ricci A, Pelaia G, Paggiaro P, Rogliani P. Sposato B, et al. Among authors: carpagnano ge. Pulm Pharmacol Ther. 2020 Apr;61:101899. doi: 10.1016/j.pupt.2020.101899. Epub 2020 Jan 21. Pulm Pharmacol Ther. 2020. PMID: 31972327
Omalizumab as add-on therapy in a patient with severe asthma and OSA.
Scioscia G, Buonamico E, Foschino Barbaro MP, Lacedonia D, Sabato R, Carpagnano GE. Scioscia G, et al. Among authors: carpagnano ge. Respirol Case Rep. 2020 Feb 7;8(2):e0518. doi: 10.1002/rcr2.518. eCollection 2020 Mar. Respirol Case Rep. 2020. PMID: 32055401 Free PMC article.
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.
Carpagnano GE, Pelaia C, D'Amato M, Crimi N, Scichilone N, Scioscia G, Resta O, Calabrese C, Pelaia G, Quarato CMI, Foschino Barbaro MP. Carpagnano GE, et al. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620929231. doi: 10.1177/1753466620929231. Ther Adv Respir Dis. 2020. PMID: 32482128 Free PMC article.
216 results